Business Description
Cizzle Biotechnology Holdings PLC
ISIN : GB00BNG2VN02
Total Employee Number:
5Description
Cizzle Biotechnology Holdings PLC is a holding company of a group of companies (the Group) whose principal activity is the early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. Designed as a simple blood test, it enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.77 | |||||
Equity-to-Asset | -1.39 | |||||
Debt-to-Equity | -0.44 | |||||
Debt-to-EBITDA | -0.21 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 12.6 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | 30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.64 | |||||
9-Day RSI | 42.07 | |||||
14-Day RSI | 41.62 | |||||
3-1 Month Momentum % | 30.91 | |||||
6-1 Month Momentum % | 157.14 | |||||
12-1 Month Momentum % | 132.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.42 | |||||
Quick Ratio | 0.42 | |||||
Cash Ratio | 0.2 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -208.55 | |||||
ROIC % | -189.29 | |||||
3-Year ROIIC % | -13.8 | |||||
ROC (Joel Greenblatt) % | -36550 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -10.69 | |||||
EV-to-Forward-EBIT | -3.38 | |||||
EV-to-EBITDA | -10.69 | |||||
EV-to-FCF | -17.43 | |||||
Earnings Yield (Greenblatt) % | -9.35 | |||||
FCF Yield % | -6.34 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cizzle Biotechnology Holdings PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.002 | ||
| Beta | -0.1167 | ||
| 3-Year Sharpe Ratio | 0.53 | ||
| 3-Year Sortino Ratio | 1.08 | ||
| Volatility % | 61.46 | ||
| 14-Day RSI | 41.62 | ||
| 14-Day ATR (€) | 0.000797 | ||
| 20-Day SMA (€) | 0.023 | ||
| 12-1 Month Momentum % | 132.26 | ||
| 52-Week Range (€) | 0.0125 - 0.0395 | ||
| Shares Outstanding (Mil) | 424.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cizzle Biotechnology Holdings PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cizzle Biotechnology Holdings PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-09-30 | In 60 days | ||
| General meeting for 2025 | 2026-06-16 10:00 | 0.03 (+4.92%) | ||
| Annual report for 2025 | 2026-04-30 | 0.03 (-6.78%) | ||
| Second quarter earnings results for 2025 | 2025-09-30 | 0.02 (-5.41%) | ||
| General meeting for 2024 | 2025-06-30 11:00 | 0.02 (+0.00%) | ||
| Annual report for 2024 | 2025-04-30 | 0.02 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2024-09-30 | 0.02 (-4.35%) |
Show
Entries
Cizzle Biotechnology Holdings PLC Frequently Asked Questions
What is Cizzle Biotechnology Holdings PLC(FRA:E7F0)'s stock price today?
The current price of FRA:E7F0 is €0.02. The 52 week high of FRA:E7F0 is €0.04 and 52 week low is €0.01.
When is next earnings date of Cizzle Biotechnology Holdings PLC(FRA:E7F0)?
The next earnings date of Cizzle Biotechnology Holdings PLC(FRA:E7F0) is 2026-09-30 Est..
Does Cizzle Biotechnology Holdings PLC(FRA:E7F0) pay dividends? If so, how much?
Cizzle Biotechnology Holdings PLC(FRA:E7F0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Cizzle Biotechnology Holdings PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers